# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-18-003259
Filing Date
2018-04-27
Accepted
2018-04-27 06:08:31
Documents
9
Period of Report
2018-06-07
Effectiveness Date
2018-04-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | a2235408zdef14a.htm | DEF 14A | 948989
2 | G429299.JPG | g429299.jpg | GRAPHIC | 23328
3 | G650180.JPG | g650180.jpg | GRAPHIC | 8714
4 | G245976.JPG | g245976.jpg | GRAPHIC | 8525
5 | G677153.JPG | g677153.jpg | GRAPHIC | 32369
6 | G144310.JPG | g144310.jpg | GRAPHIC | 31749
7 | G28372CGI001.GIF | g28372cgi001.gif | GRAPHIC | 101625
8 | G28372CII001.GIF | g28372cii001.gif | GRAPHIC | 123782
9 | G28372CKI001.GIF | g28372cki001.gif | GRAPHIC | 175372
| Complete submission text file | 0001047469-18-003259.txt |  | 1647028

Mailing Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512
Business Address 1 CEDAR BROOK DRIVE CRANBURY NJ 08512 (609) 662-2000
AMICUS THERAPEUTICS INC (Filer) CIK: 0001178879 (see all company filings)

EIN.: 200422823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33497 | Film No.: 18780867
SIC: 2834 Pharmaceutical Preparations